Chemoinformaics analysis of 2-METHYLPROPYL BENZOATE
| Molecular Weight | 178.231 | nRot | 3 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 2 |
| Exact Molecular Weight | 178.099 | nRing | 1 |
| Solubility: LogS | -6.229 | nHRing | 0 |
| Solubility: LogP | 7.119 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 29.3091 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.195 |
| Synth | 2.237 |
| Natural Product Likeliness | 1.044 |
| NR-PPAR-gamma | 0.663 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -4.755 |
| MDCK | 0.0000116 |
| BBB | 0.799 |
| PPB | 0.961324 |
| VDSS | 3.803 |
| FU | 0.0168921 |
| CYP1A2-inh | 0.361 |
| CYP1A2-sub | 0.187 |
| CYP2c19-inh | 0.396 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.212 |
| CYP2c9-sub | 0.946 |
| CYP2d6-inh | 0.391 |
| CYP2d6-sub | 0.181 |
| CYP3a4-inh | 0.349 |
| CYP3a4-sub | 0.04 |
| CL | 4.113 |
| T12 | 0.143 |
| hERG | 0.268 |
| Ames | 0.019 |
| ROA | 0.009 |
| SkinSen | 0.983 |
| Carcinogencity | 0.183 |
| EI | 0.946 |
| Respiratory | 0.932 |
| NR-Aromatase | 0.318 |
| Antiviral | No |
| Prediction | 0.712331 |